skip to main content

Morpheus8 - InMode

July 2024 : Additional FDA 510(k) clearance for the Morpheus8 technology. 

Morpheus8 has been given the first and only fractional radiofrequency (FRF) microneedling technology clearance by the FDA for contraction of soft tissue.

The delivery of fractional radiofrequency by this technology enables treatment of your skin where coagulation/contraction of soft tissue or hemostasis is needed. This FDA action expands Morpheus8's existing FDA clearance.

If you are interested in learning more about the Morpheus 8 treatment, please  Contact us to arrange a consultation and discuss the procedures that would suit your particular requirements .

Back to News

Back to News